An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Clinical trial NCT02172950 · COMPLETED
Trial details
- NCT number
- NCT02172950
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2021-01-19
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.